PCM
SLS icon

Pinz Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Pinz Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,700
Closed -$119K – 366
2021
Q2 		$119K Sell
10,700
-2,400
-18% -$23.4K 0.04% 175
2021
Q1 		$112K Buy
+13,100
New +$107K 0.03% 193

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pinz Capital Management's SLS Position: Q3 2021 in Review

Pinz Capital Management sold out of SELLAS Life Sciences (SLS) in Q3 2021, closing a stake of 10,700 shares — an estimated $119K sold.

Pinz Capital Management first reported a position in SLS in Q1 2021 and held it in 2 quarters. The position peaked at $119K in Q2 2021. 30 funds tracked by Wall St. Rank hold SLS as of Q3 2021.

  • Pinz Capital Management reported no remaining SELLAS Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Pinz Capital Management sold 10,700 SELLAS Life Sciences shares in Q3 2021, an estimated $119K.
  • Pinz Capital Management first reported a position in SELLAS Life Sciences in Q1 2021 and held it in 2 quarters.
  • Pinz Capital Management's SELLAS Life Sciences position peaked at $119K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.